A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes Treated With Once-daily Basal Insulin With or Without Metformin
Clinical trial NCT06323161 · COMPLETED
Trial details
- NCT number
- NCT06323161
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-26
- Primary completion
- 2025-09-09
- Enrollment
- 274
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.